Compugen (CGEN) EBITDA Margin (2009 - 2026)
Compugen's (CGEN) quarterly EBITDA Margin came in at 414.38% in Q1 2026, up 4683.0% year-on-year from 8.66% in Q1 2025, and up 397.86% quarter-over-quarter from 83.23% in Q4 2025.
Compugen (CGEN) EBITDA Margin (2009 - 2026) Analysis & Trends
Compugen has disclosed EBITDA Margin across 15 years of filings, most recently posting 414.38% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 414.38%, up 4683.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 43.97% (up 9830.0% YoY), and the FY2025 annual result was 43.05%, up 9649.0% from the prior year.
- EBITDA Margin came in at 414.38% for Q1 2026 at Compugen, up from 83.23% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 414.38% in Q1 2026 to a low of 2006.28% in Q2 2025.
- The 5-year median for EBITDA Margin is 26.24% (2024), against an average of 182.43%.
- Peak annual rise in EBITDA Margin reached 59194 bps in 2025, while the deepest fall reached 170196 bps in 2025.
- Compugen's EBITDA Margin stood at 47.05% in 2022, then surged by 214 bps to 53.75% in 2023, then slumped by 1046 bps to 508.7% in 2024, then jumped by 116 bps to 83.23% in 2025, then surged by 398 bps to 414.38% in 2026.
- The last three EBITDA Margin figures came in at 414.38% (Q1 2026), 83.23% (Q4 2025), and 417.4% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 414.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 414.38% |
| Dec 31, 2025 | 83.23% |
| Sep 30, 2025 | -417.40% |
| Jun 30, 2025 | -2,006.28% |
| Mar 31, 2025 | 367.56% |
| Dec 31, 2024 | -508.70% |
| Sep 30, 2024 | 26.24% |
| Jun 30, 2024 | -304.33% |
| Mar 31, 2024 | 331.85% |
| Dec 31, 2023 | 53.75% |
| Dec 31, 2022 | -47.05% |
| Sep 30, 2021 | -105.55% |
| Dec 31, 2020 | -454.55% |
| Sep 30, 2018 | -42.72% |
| Mar 31, 2018 | 1.15% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -11,381.43% |
| Jun 30, 2016 | -1,412.90% |
| Mar 31, 2016 | -9,538.71% |
| Dec 31, 2015 | -8.75% |